Federal contractor · SHIRLEY, NY
CREATIVE BIOLABS INC
CREATIVE BIOLABS INC received $225.7K in federal contract obligations in FY2026, on 4 awards (+84% vs FY2025). Since FY2018: $1.2M. Its largest customer was National Institutes of Health ($176.8K).
- Obligations · FY2026
- $225.7K
- New awards
- 4
- Sole-source
- 0.0%
- Single offer
- 100%
- UEI
- V595TMBX2117
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 68.3KFY2018
- 24.4KFY2019
- 65KFY2020
- 210KFY2021
- 23.4KFY2022
- 49.9KFY2023
- 367.2KFY2024
- 122.6KFY2025
- 225.7KFY2026
Top buying agencies
Obligations in FY2026.
- National Institutes of Health$176.8K78%2 awards
- 1 awards
- Agricultural Research Service$15.9K7.0%1 awards
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
- Other equipment & supplies$176.8K78%
- Research & development$33K15%
- Health & medical$15.9K7.0%
Where the work was performed
- Suffolk County, NY$192.7K85%
- Baltimore city, MD$33K15%
Integrity signals
Shares of the year's obligations, next to the country's.
- Low competition100%US 39% · $225.7K
- Sole-source awards0.0%US 30% · $0
- Single-offer competitions100%US 8.8% · $225.7K
- Urgency justifications0.0%US 5.1% · $0
A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.
Largest awards
- National Institutes of Health· Suffolk County, NY· Other equipment & supplies· Aug 10, 2026 – Aug 10, 2026· 75N98026P01252
- National Institutes of Health· Suffolk County, NY· Other equipment & supplies· Aug 10, 2026 – Aug 10, 2026· 75N98026P01288
- Department of Veterans Affairs· Baltimore city, MD· Research & development· Sep 21, 2026 – Sep 21, 2026· 36C24526P0656
- Agricultural Research Service· Suffolk County, NY· Health & medical· Sep 9, 2026 – Sep 9, 2026· 1232SA26P0601
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
CREATIVE BIOLABS INC received $0 in federal assistance in FY2026, on 0 actions (0 new awards).
- Assistance · FY2026
- $0
- New awards
- 0
- Actions
- 0
Assistance by fiscal year
- 500KFY2023
Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2023.
Competitors
Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.
Compared on 6 markets (agency × industry), FY2024–FY2026.
- COLUMBUS NANOWORKS, INC.$506.5K−100% in FY2026COLUMBUS, OH · 71% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
- GENCYTE THERAPEUTICS INC$500K−100% in FY2026SAN CARLOS, CA · 70% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
- EYDIS BIO, INC.$499.8K−100% in FY2026DURHAM, NC · 70% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
Showing the top 3 of 25 competitors. Open the profile for the full list.
Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2024–FY2026.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026.